Scientists hunt for genetic clues in chest cancers
NCT ID NCT00242723
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 39 times
Summary
This study enrolls people with lung, esophageal, or other chest cancers to collect tumor tissue, normal tissue, blood, and urine samples. Researchers will analyze these samples for genetic and epigenetic changes that may affect how the disease progresses. The goal is to better understand these cancers and identify patients who might benefit from future treatment trials at the National Cancer Institute.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could point toward new treatments for lung, esophageal, and other chest cancers by identifying key genetic changes.
What could go wrong
This is an observational study, not a treatment trial. It collects samples for research, so there is no direct benefit to participants. Results may take years to influence patient care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.